Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients
Authors
Keywords
Recurrent glioma, 1,3-bis (2-chloroethyl)-1-nitroso-urea (BCNU), Survival after relapse, Side effects, Pulmonary fibrosis
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-10
DOI
10.1186/s12885-016-2131-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bevacizumab for Recurrent Glioblastoma Multiforme: A Meta-Analysis
- (2017) Eric T. Wong et al. Journal of the National Comprehensive Cancer Network
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma
- (2012) Stephanie E. Combs et al. ACTA ONCOLOGICA
- Temozolomide Dosing Regimens for Glioma Patients
- (2012) Herwig M. Strik et al. Current Neurology and Neuroscience Reports
- The efficacy of temozolomide for recurrent glioblastoma multiforme
- (2012) Chao Chen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Impact of extent of resection for recurrent glioblastoma on overall survival
- (2012) Orin Bloch et al. JOURNAL OF NEUROSURGERY
- Multiple resections for patients with glioblastoma: prolonging survival
- (2012) Kaisorn L. Chaichana et al. JOURNAL OF NEUROSURGERY
- Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?
- (2011) C. Hartmann et al. CLINICAL CANCER RESEARCH
- Controversies in the Adjuvant Therapy of High-Grade Gliomas
- (2011) M. Holdhoff et al. ONCOLOGIST
- Improvement, Clinical Course, and Quality of Life After Palliative Radiotherapy for Recurrent Glioblastoma
- (2010) Carsten Nieder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
- (2010) Thomas Reithmeier et al. BMC CANCER
- Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas
- (2010) Marc C Chamberlain Expert Review of Neurotherapeutics
- Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
- (2010) John K. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- (2009) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors
- (2009) David Capper et al. BRAIN PATHOLOGY
- NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
- (2009) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
- (2009) et al. NEUROSURGERY
- Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent Glioblastoma
- (2009) M. Glas et al. ONCOLOGY
- ACNU-based chemotherapy for recurrent glioma in the temozolomide era
- (2008) Caroline Happold et al. JOURNAL OF NEURO-ONCOLOGY
- Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients
- (2008) Johannes E. A. Wolff et al. JOURNAL OF NEURO-ONCOLOGY
- Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
- (2007) Thierry Gorlia et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now